Fig. 1From: Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson’s diseaseBrain magnetic resonance imaging (MRI) changes in a patient with Wilson’s disease prior to and after 1 year of treatment. Compared with prior treatment (a − c), abnormal signal intensities in basal ganglia, thalamus, and midbrain were all obviously altered after 1 year of combined therapy (d − f)Back to article page